# OnCo record paper-pioneer-avapritinib-indolent-systemic-mastocytosis-nejm-evid-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-pioneer-avapritinib-indolent-systemic-mastocytosis-nejm-evid-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-pioneer-avapritinib-indolent-systemic-mastocytosis-nejm-evid-2023" ;
  schema:name "PIONEER: avapritinib versus placebo in indolent systemic mastocytosis"@en ;
  schema:description "A low dose of the KIT inhibitor avapritinib eased the itching, flushing, gut and bone symptoms of indolent systemic mastocytosis more than placebo, the first drug shown to do so in a randomised trial."@en ;
  schema:url <https://onco.cc/key-papers/paper-pioneer-avapritinib-indolent-systemic-mastocytosis-nejm-evid-2023/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/EVIDoa2200339>, <https://pubmed.ncbi.nlm.nih.gov/38320129/> ;
  schema:sameAs <https://doi.org/10.1056/EVIDoa2200339> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Gotlib J, Castells M, Elberink HO, et al." ;
  onco:cancers <https://onco.cc/cancers/indolent-systemic-mastocytosis/> ;
  onco:drugs <https://onco.cc/drugs/avapritinib/> ;
  onco:journals <https://onco.cc/journals/nejm-evidence/> .